Literature DB >> 2479680

High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients.

P Casali1, S E Burastero, J E Balow, A L Notkins.   

Abstract

It was previously shown that human CD5+B cells are committed to the production of polyreactive "autoantibodies" that bind different self-Ag, including ssDNA, IgG Fc fragment, thyroglobulin, and insulin, as well as exogenous Ag, e.g., tetanus toxoid and other bacterial components. To define the contribution of the CD5+B cell subset to the production of antibodies to ssDNA in SLE, we quantitated, purified, and functionally characterized circulating CD5+ and CD5-B cells in patients and in healthy subjects. We found that in SLE patients circulating CD5+B cells were not increased in number, and both CD5+ and C5-B cells spontaneously secreted antibodies to ssDNA. Studies of the mAb we generated using CD5+ and CD5-B cells revealed that two types of antibody to ssDNA are produced in SLE. The first type, of the IgM class, is produced mainly by CD5+B cells and displays a moderate affinity for ssDNA (Kd, 10(-6) to 10(-7) mol/liter) and is polyreactive, not dissimilar to the autoantibodies inducible in the normal human B cell repertoire by polyclonal activation. The second type, mostly of the IgG and IgA class, is produced mainly by CD5-B cells and displays a higher affinity (Kd, 10(-8) mol/liter) for and reacts only with ssDNA. The functional features of the high affinity anti-ssDNA antibodies and the phenotype of their producing B cells mimic those characteristic of a "mature" Ag-driven response, such as that to tetanus toxoid in tetanus toxoid-vaccinated subjects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479680

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

2.  Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Authors:  Z-H Zhou; A L Notkins
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 3.  Generation of stable human autoantibody-secreting B cell hybridomas.

Authors:  N Chiorazzi
Journal:  Mol Biol Rep       Date:  1992-05       Impact factor: 2.316

4.  CD5 expression on B cells may be an activation marker for secretion of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammopathy.

Authors:  C Ekerfelt; J Ernerudh; G Solders; M Vrethem
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

5.  Synthesis of anti-acetylcholine receptor antibodies by CD5- B cells from peripheral blood of myasthenia gravis patients.

Authors:  F Heidenreich; T Jovin
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

6.  Establishment and characterization of a human B cell line producing IgG type antibodies to DNA.

Authors:  Y Maeda; F Horiuchi; J Miyatake; M Ohno; K Irimajiri; A Horiuchi
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

7.  CD5+ B lymphocytes in systemic lupus erythematosus patients: relation to disease activity.

Authors:  Hanan Hassan Omar; Samah Ismail Nasef; Hamdy Hassan Omar; Mona Sayed Ghaly
Journal:  Clin Rheumatol       Date:  2017-09-16       Impact factor: 2.980

8.  Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.

Authors:  M Satoh; A Kumar; Y S Kanwar; W H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli.

Authors:  S C Cheung; S Takeda; A L Notkins
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

10.  Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice.

Authors:  Ling-Ling Zhou; Wei Wei; Jun-Feng Si; Dong-Ping Yuan
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.